Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Recommendations for the conduct of efficacy trials of treatment devices for osteoarthritis: a report from a working group of the Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Group: Box 1

Felson, David T., Redmond, Anthony C., Chapman, Graham J., Smith, Toby O., Hamilton, David F., Jones, Richard K., Holt, Catherine Avril, Callaghan, Michael J., Mason, Deborah Jane and Conaghan, Philip G. 2016. Recommendations for the conduct of efficacy trials of treatment devices for osteoarthritis: a report from a working group of the Arthritis Research UK Osteoarthritis and Crystal Diseases Clinical Studies Group: Box 1. Rhuematology 55 (2) , pp. 320-326. 10.1093/rheumatology/kev328

Full text not available from this repository.

Abstract

Objective. There are unique challenges to designing and carrying out high-quality trials testing therapeutic devices in OA and other rheumatic diseases. Such challenges include determining the mechanisms of action of the device and the appropriate sham. Design of device trials is more challenging than that of placebo-controlled drug trials. Our aim was to develop recommendations for designing device trials. Methods. An Arthritis Research UK study group comprised of 30 rheumatologists, physiotherapists, podiatrists, engineers, orthopaedists, trialists and patients, including many who have carried out device trials, met and (using a Delphi-styled approach) came to consensus on recommendations for device trials. Results. Challenges unique to device trials include defining the mechanism of action of the device and, therefore, the appropriate sham that provides a placebo effect without duplicating the action of the active device. Should there be no clear-cut mechanism of action, a three-arm trial including a no-treatment arm and one with presumed sham action was recommended. For individualized devices, generalizable indications and standardization of the devices are needed so that treatments can be generalized. Conclusion. A consensus set of recommendations for device trials was developed, providing a basis for improved trial design, and hopefully improvement in the number of effective therapeutic devices for rheumatic diseases.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Engineering
Subjects: Q Science > QM Human anatomy
T Technology > TJ Mechanical engineering and machinery
Publisher: Oxford University Press
ISSN: 1462-0324
Date of Acceptance: 5 August 2015
Last Modified: 08 Mar 2019 16:44
URI: http://orca.cf.ac.uk/id/eprint/76823

Citation Data

Cited 8 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item